
Sign up to save your podcasts
Or


Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) review expanded MERINO trial data including mortality by pathogen MIC, PK-PD principles, BLING III, beta-lactam therapeutic drug monitoring, linezolid dosing in renal impairment, microbiology issues, and updates from EUCAST.
CORRECTION: Piperacillin-tazobactam was dosed 4.5g IV every 6 hours in the Merino trial.
Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About
By Society of Infectious Diseases Pharmacists4.9
169169 ratings
Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) review expanded MERINO trial data including mortality by pathogen MIC, PK-PD principles, BLING III, beta-lactam therapeutic drug monitoring, linezolid dosing in renal impairment, microbiology issues, and updates from EUCAST.
CORRECTION: Piperacillin-tazobactam was dosed 4.5g IV every 6 hours in the Merino trial.
Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About

321 Listeners

2,053 Listeners

504 Listeners

130 Listeners

3,374 Listeners

1,150 Listeners

518 Listeners

260 Listeners

437 Listeners

188 Listeners

29 Listeners

91 Listeners

270 Listeners

3 Listeners

10 Listeners